5-(N,N-Hexamethylene)amiloride
5-(N,N-Hexamethylene)amiloride is a derivative of the diuretic drug amiloride, which is primarily known for its role as a potassium-sparing diuretic. This compound is of interest in the field of pharmacology due to its ability to inhibit certain ion channels and transporters, particularly the sodium-hydrogen exchanger (NHE).
Chemical Structure and Properties[edit | edit source]
5-(N,N-Hexamethylene)amiloride is a modified version of amiloride, where the pyrazine ring is substituted with a hexamethylene group. This modification alters its pharmacokinetic and pharmacodynamic properties, potentially enhancing its specificity and potency against certain targets.
Molecular Formula[edit | edit source]
The molecular formula of 5-(N,N-Hexamethylene)amiloride is C12H18N4O.
Molecular Weight[edit | edit source]
The molecular weight of this compound is approximately 234.3 g/mol.
Mechanism of Action[edit | edit source]
5-(N,N-Hexamethylene)amiloride functions primarily as an inhibitor of the sodium-hydrogen exchanger (NHE), a membrane protein that plays a critical role in regulating intracellular pH and cell volume. By inhibiting NHE, this compound can affect various physiological processes, including cell proliferation, migration, and apoptosis.
Pharmacological Effects[edit | edit source]
The pharmacological effects of 5-(N,N-Hexamethylene)amiloride are largely attributed to its ability to modulate ion transport across cell membranes. This can lead to changes in cellular homeostasis and has potential therapeutic implications in conditions such as hypertension, heart failure, and certain types of cancer.
Research and Clinical Applications[edit | edit source]
Research into 5-(N,N-Hexamethylene)amiloride has focused on its potential use in treating diseases characterized by dysregulated ion transport. Studies have explored its effects in models of cardiovascular disease, cancer, and other conditions where NHE activity is implicated.
Safety and Toxicity[edit | edit source]
As with any pharmacological agent, the safety and toxicity profile of 5-(N,N-Hexamethylene)amiloride must be thoroughly evaluated. Preclinical studies are necessary to assess its potential side effects and therapeutic window.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD